212 related articles for article (PubMed ID: 24684686)
1. Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma.
Portela RF; Fadl-Alla BA; Pondenis HC; Byrum ML; Garrett LD; Wycislo KL; Borst LB; Fan TM
J Vet Intern Med; 2014; 28(3):894-904. PubMed ID: 24684686
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K expression and activity in canine osteosarcoma.
Schmit JM; Pondenis HC; Barger AM; Borst LB; Garrett LD; Wypij JM; Neumann ZL; Fan TM
J Vet Intern Med; 2012; 26(1):126-34. PubMed ID: 22171552
[TBL] [Abstract][Full Text] [Related]
3. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
[TBL] [Abstract][Full Text] [Related]
4. Expression of nociceptive ligands in canine osteosarcoma.
Shor S; Fadl-Alla BA; Pondenis HC; Zhang X; Wycislo KL; Lezmi S; Fan TM
J Vet Intern Med; 2015 Jan; 29(1):268-75. PubMed ID: 25572473
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma.
Byrum ML; Pondenis HC; Fredrickson RL; Wycislo KL; Fan TM
J Vet Intern Med; 2016 Jul; 30(4):1187-96. PubMed ID: 27251585
[TBL] [Abstract][Full Text] [Related]
6. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
7. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.
Marley K; Bracha S; Seguin B
Exp Cell Res; 2015 Oct; 338(1):32-8. PubMed ID: 26254896
[TBL] [Abstract][Full Text] [Related]
9. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.
Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC
J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
11. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
Disatian S; Orton EC
J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
[TBL] [Abstract][Full Text] [Related]
12. Autocrine production of reproductive axis neuropeptides affects proliferation of canine osteosarcoma in vitro.
Weinman MA; Fischer JA; Jacobs DC; Goodall CP; Bracha S; Chappell PE
BMC Cancer; 2019 Feb; 19(1):158. PubMed ID: 30777054
[TBL] [Abstract][Full Text] [Related]
13. Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome.
Alfino LN; Wilczewski-Shirai KC; Cronise KE; Coy J; Glapa K; Ehrhart EJ; Charles JB; Duval DL; Regan DP
Vet Pathol; 2021 Sep; 58(5):981-993. PubMed ID: 33685296
[TBL] [Abstract][Full Text] [Related]
14. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the metabolic role of STAT3 in canine osteosarcoma.
Gardner HL; Fenger JM; Roberts RD; London CA
Vet Comp Oncol; 2022 Dec; 20(4):817-824. PubMed ID: 35608271
[TBL] [Abstract][Full Text] [Related]
16. Urine N-telopeptide excretion in dogs with appendicular osteosarcoma.
Lacoste H; Fan TM; de Lorimier LP; Charney SC
J Vet Intern Med; 2006; 20(2):335-41. PubMed ID: 16594591
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2.
Kimura C; Hayashi M; Mizuno Y; Oike M
Biochim Biophys Acta; 2013 Oct; 1830(10):4470-81. PubMed ID: 23668958
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the sis oncogene in a canine osteosarcoma cell line.
Levine RA
Vet Pathol; 2002 May; 39(3):411-2. PubMed ID: 12014510
[TBL] [Abstract][Full Text] [Related]
19. miR-1 and miR-133b expression in canine osteosarcoma.
Leonardo L; Laura P; Serena BM
Res Vet Sci; 2018 Apr; 117():133-137. PubMed ID: 29272721
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
